Screener
Madrigal Pharmaceuticals, Inc. MDGL Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s current debt?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported current debt of $30.1M in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s current debt changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s current debt increased by 159.5% year-over-year, from $11.6M to $30.1M.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude